Public Company News

WuXi Biologics Reports Strong 2021 Interim Results

* Revenue Increases by 126.7% Y-o-Y to RMB4,406.8 Million * Gross Profit Grows by 191.7% Y-o-Y to RMB2,296.8 Million * Adjusted Net Profit Attributable to Owners of the Company Increases by 163.0% Y-o-Y toRMB1,768.7 Million * Gross and Net Profit Margins Reach 52.1% and 42.7%, Respectively ...

2021-08-23 20:59 4486

uCloudlink and Zaffari Bring Better Data Connectivity to South America

HONG KONG, Aug. 23, 2021 /PRNewswire/ -- UCLOUDLINK GROUP INC. (NASDAQ: UCL, "uCloudlink"), the world's first and leading mobile data traffic sharing marketplace, has inked a new partnership agreement with Zaffari Sports S.A.S. ("Zaffari"), a sports and outdoor retailer based inMedellin, Colombia...

2021-08-23 20:30 4701

Study Confirms Viraleze Antiviral Nasal Spray Provides Protection Against SARS-CoV-2 in Challenge Model

MELBOURNE, Australia, Aug. 23, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma has announced the publication of new data demonstrating the capability of its Viraleze antiviral nasal spray to protect against SARS-CoV-2 in an animal challenge model of SARS-CoV-2 infection[1]. Viraleze adm...

2021-08-23 20:23 4608

NetDragon Signs MOU with Thailand MoE to Launch English Smart Classroom Lab Project

HONG KONG, Aug. 23, 2021 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or the "Company"; Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that the Company has signed a memorandum of understanding ("MOU") with the Office of the ...

2021-08-23 19:06 4652

RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib for Ebola Virus and RHB-104 for Crohn's

U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035 Opaganib's 475-patient global Phase 2/3 study in severe COVID-19 approaching completion with upcoming top-line results Opaganib also undergoing two oncology Phase 2 U.S. studies a...

2021-08-23 19:00 4741

"Fueling the Culinary Fire" by Marriott Bonvoy Explores the Creative Minds of Some of Hong Kong and Macau's Greatest Chefs

HONG KONG, Aug. 23, 2021 /PRNewswire/ -- Marriott Bonvoy has recently launched a six-part video series, "Fueling the Culinary Fire", a special glimpse behind the scenes and inside the minds of the greatest Michelin-starred chefs inHong Kong and Macau. From Chef de Cuisine Paul Lau of Tin Lung Hee...

2021-08-23 17:03 3549

Vinamilk ramps up R&D efforts to win big globally

HO CHI MINH CITY, Vietnam, Aug. 23, 2021 /PRNewswire/ -- The Vietnam Dairy Products JSC (Vinamilk) is accelerating R&D efforts to create innovative products enriched with local flavours to satisfy global customers' diverse tastes. With its strategic investment in product development, internation...

2021-08-23 16:41 9738

CNOOC Limited Announces Luda 6-2 Oilfield Commences Production

HONG KONG, Aug. 23, 2021 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883, NYSE: CEO, TSX: CNU) today announced that Luda 6-2 oilfield has commenced production ahead of schedule. Luda 6-2 oilfield is located in Liaodong Bay of Bohai Sea, with average water depth of about 30 meters. In...

2021-08-23 16:39 3111

FinVolution Group Reports Second Quarter 2021 Unaudited Financial Results

SHANGHAI, Aug. 23, 2021 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2021. For the Three Months Ended YoY Change June 30, 2...

2021-08-23 15:45 1807

Everest Medicines to Announce Half-Year 2021 Interim Results

SHANGHAI, Aug. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced t...

2021-08-23 15:20 3864

Inclusion of Kintor as a Constituent Stock of HSCI

SUZHOU, China, Aug. 23, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company's stock has been included in the Hang Seng Composite ...

2021-08-23 08:44 3664

Risen Energy expands Power Purchase Agreement with BHP to further cut Nickel West's emissions

NINGBO, China, Aug. 23, 2021 /PRNewswire/ -- Risen Energy has expanded its 10-year renewable power purchase agreement (PPA) for their Merredin Solar Farm from 20MW to 50MW of electricity to BHP's Nickel West operations.  Commencing on 1st August, the additional 30MW will be directed to BHP Nickel...

2021-08-23 08:00 4889

JCET 1H 2021 Net Profit Jumps 261%, Earnings Surpass FY 2020 Mark

Q2 2021 Financial Highlights: * Revenue was RMB 7.11 billion, an increase of 13.4% year on year. A record high second quarter in the company's history. * Generated RMB 1.68 billion cash from operations, an increase of 67.1% year on year. With net capex investments ofRMB 0.92 billion, f...

2021-08-21 00:23 6142

Ocumension Therapeutics Announces 2021 Interim Results

Company loss narrowed sharply by 96% Business Income Increased By More Than 26 Times Year-on-Year Core Product OT-401 Approval Imminent HONG KONG, Aug. 21, 2021 /PRNewswire/ -- The Chinese ophthalmology platform company,Ocumension Therapeutics ("Ocumension" or the "Company", together with its s...

2021-08-21 00:19 17582

CStone Pharmaceuticals Selected as a Constituent of HSCI

SUZHOU, China, Aug. 20, 2021 /PRNewswire/ -- CStone Pharmaceuticals (HKEX: 2616, "CStone" or the "Company"), a leading biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology therapies and precision medicines, announced that the Company has bee...

2021-08-20 20:24 6697

Bambuser CEO and CFO comment on the Interim Report for Q2 2021

STOCKHOLM, Aug. 20, 2021 /PRNewswire/ -- Maryam Ghahremani, CEO and Sara Lundell CFO of Bambuser, will comment on the interim report from the second quarter of 2021. The interview will be broadcast today at15:00 CEST, 9 AM EDT, held in English and last for approx 15 minutes. Link to the broadcas...

2021-08-20 20:17 3822

JW Therapeutics Announces Strategic Partnership with MediTrust Health

SHANGHAI, Aug. 20, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy, today announced that it has entered into a strategic partnership with MediTrust Health. Leveraging the respective ...

2021-08-20 17:00 34957

Trina Solar sets new world record of production 210 PERC cell with efficiency reaching 23.56%

CHANGZHOU, China, Aug. 20, 2021 /PRNewswire/ -- Trina Solar's State Key Laboratory of PV Science and Technology (SKL PVST) announced its proprietary industrial larger-area210mm×210mm high-efficiency PERC solar cell in mass production, has achieved the efficiency of 23.56%, setting a new record for...

2021-08-20 15:22 14217

Bambuser AB Publishes Interim Report for Q2 2021

STOCKHOLM, Aug. 20, 2021 /PRNewswire/ -- For the second consecutive quarter, Bambuser experienced its best results since inception. In addition to strong global demand, the company continues to grow its relationships with large enterprises and conglomerates, resulting in a sales lift of +664 perc...

2021-08-20 14:50 11874

TERA-Award offers US$1 million prize, applications to close 31 August

HONG KONG, Aug. 20, 2021 /PRNewswire/ -- The inaugural TERA-Award smart energy innovation competition co-organised by TheHong Kong and China Gas Company Limited (Towngas) and State Power Investment Company Limited (SPIC) under the theme of "exploring zero-carbon innovations for the future" is acc...

2021-08-20 14:00 43251
1 ... 781782783784785786787 ... 891